DON'T BUY
This could be a time when money moves back into the health care. Usually the small cap biotech stocks, such as Biovale (BVF-T), Patheon (PTI-T), MDS (MDS-T), etc. move together. Don't just buy one, buy 3 or 4 of them. This one is a pretty thin trader, so would stay away from it.
biotechnology / pharmaceutical

Unlock the latest expert's opinion. Its free

Create a FREE account to see the latest opinions & get alerts about when to buy, sell or hold stocks

Unlock the latest opinion & get signals
DON'T BUY
Consolidated stock at 4 to 1 to meet Nasdaq requirements. Markets hate reverse consolidations. Typically it's not a good sign as it means you've got too many shares outstanding. Not a great company, so wouldn't expect a whole lot from this company in the future.
biotechnology / pharmaceutical
TRADE
Speculative future.
biotechnology / pharmaceutical
BUY
It will expire again, company has run out of money many times. Take money out, while money is on the table.
biotechnology / pharmaceutical
SELL
Basically, you are paying for an option. The company has run out of money many times and they continue to have regulatory problems with their product.
biotechnology / pharmaceutical
DON'T BUY
Built a nice plant in Mississauga, but found they had trouble with their blood substitute. Now a speculative stock.
biotechnology / pharmaceutical
DON'T BUY
Have made arrangements with another biotech company by contracting for part of their facility. Should be getting some revenues. Not a fan.
biotechnology / pharmaceutical
DON'T BUY
A speculative play. Hemalink stalled in face two clinical trials. Build a plant. Limited visibility going forward.
biotechnology / pharmaceutical
DON'T BUY
Ran into trouble with their lead product. Down to about $900,000 in cash. The company is on life support.
biotechnology / pharmaceutical
DON'T BUY
Very speculative. FDA trials didn't go well.
biotechnology / pharmaceutical
DON'T BUY
A lot of problems. May not survive.
biotechnology / pharmaceutical
DON'T BUY
A long way from being a mature company with mature products. Speculative.
biotechnology / pharmaceutical
DON'T BUY
Never seems to get it together.
biotechnology / pharmaceutical
DON'T BUY
Worst is behind them. Would prefer owning through MDS.
biotechnology / pharmaceutical
WEAK BUY
OK for a long term hold. Buy on weakness.
biotechnology / pharmaceutical
Showing 1 to 15 of 78 entries

Hemosol(HML-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Hemosol is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Hemosol(HML-T) Frequently Asked Questions

What is Hemosol stock symbol?

Hemosol is a OTC stock, trading under the symbol HML-T on the (). It is usually referred to as or HML-T

Is Hemosol a buy or a sell?

In the last year, there was no coverage of Hemosol published on Stockchase.

Is Hemosol a good investment or a top pick?

Hemosol was recommended as a Top Pick by on . Read the latest stock experts ratings for Hemosol.

Why is Hemosol stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Hemosol worth watching?

In the last year 0 stock analysts on Stockchase covered Hemosol. The stock is worth watching.

What is Hemosol stock price?

On , Hemosol (HML-T) stock closed at a price of $.